Safety Study of VM206RY in Subjects With Expression of HER2 in Breast Cancer

NCT01895491 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: VM206DNA
BIOLOGICAL: VM206Ad

Sponsor

Reyon Pharmaceutical Co., Ltd.